High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple MyelomaJ. A. Child, Peter J. Selby, Gareth J. Morgan et al.|New England Journal of Medicine|2003Cited by 1.8k
First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trialGareth J. Morgan, J. Anthony Child, Fiona Ross et al.|The Lancet|2010Cited by 571
Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed MyelomaBrian A. Walker, Gareth J. Morgan, Eileen M. Boyle et al.|Journal of Clinical Oncology|2015Cited by 564
Early Mortality After Diagnosis of Multiple Myeloma: Analysis of Patients Entered Onto the United Kingdom Medical Research Council Trials Between 1980 and 2002—Medical Research Council Adult Leukaemia Working PartyBradley Augustson, Mark T. Drayson, Gulnaz Begum et al.|Journal of Clinical Oncology|2005Cited by 489
Minimal Residual Disease Assessed by Multiparameter Flow Cytometry in Multiple Myeloma: Impact on Outcome in the Medical Research Council Myeloma IX StudyAndy C. Rawstron, Roger G. Owen, J. A. Child et al.|Journal of Clinical Oncology|2013Cited by 419